- Home
- LEGN vs BXSL Comparison
LEGN vs BXSL Comparison
Compare LEGN & BXSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- BXSL
- Stock Information
- Founded
- LEGN 2014
- BXSL 2018
- Country
- LEGN United States
- BXSL United States
- Employees
- LEGN N/A
- BXSL N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- BXSL Trusts Except Educational Religious and Charitable
- Sector
- LEGN Health Care
- BXSL Finance
- Exchange
- LEGN Nasdaq
- BXSL Nasdaq
- Market Cap
- LEGN 7.0B
- BXSL 7.5B
- IPO Year
- LEGN 2020
- BXSL N/A
- Fundamental
- Price
- LEGN $27.78
- BXSL $31.65
- Analyst Decision
- LEGN Strong Buy
- BXSL Buy
- Analyst Count
- LEGN 13
- BXSL 6
- Target Price
- LEGN $75.67
- BXSL $31.38
- AVG Volume (30 Days)
- LEGN 1.5M
- BXSL 964.2K
- Earning Date
- LEGN 05-13-2025
- BXSL 05-07-2025
- Dividend Yield
- LEGN N/A
- BXSL 9.73%
- EPS Growth
- LEGN N/A
- BXSL N/A
- EPS
- LEGN N/A
- BXSL 3.14
- Revenue
- LEGN $728,303,000.00
- BXSL $1,380,706,000.00
- Revenue This Year
- LEGN $65.96
- BXSL $12.37
- Revenue Next Year
- LEGN $52.55
- BXSL $8.12
- P/E Ratio
- LEGN N/A
- BXSL $10.08
- Revenue Growth
- LEGN 112.46
- BXSL 16.76
- 52 Week Low
- LEGN $29.27
- BXSL $25.89
- 52 Week High
- LEGN $60.87
- BXSL $34.64
- Technical
- Relative Strength Index (RSI)
- LEGN 29.61
- BXSL 64.90
- Support Level
- LEGN $30.25
- BXSL $29.07
- Resistance Level
- LEGN $33.30
- BXSL $30.04
- Average True Range (ATR)
- LEGN 1.78
- BXSL 0.52
- MACD
- LEGN -0.57
- BXSL 0.34
- Stochastic Oscillator
- LEGN 5.19
- BXSL 98.20
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About BXSL Blackstone Secured Lending Fund of Beneficial Interest
Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities.